SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-07-001043
Filing Date
2007-02-26
Accepted
2007-02-26 13:37:23
Documents
3
Period of Report
2007-02-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS, INC. b64268aie8vk.htm 8-K 12399
2 EX-10.1 EMPLOYMENT AGREEMENT DATED FEBRUARY 20, 2007--SHALINI SHARP b64268aiexv10w1.txt EX-10.1 50435
3 EX-10.2 EMPLOYMENT AGREEMENT DATED FEBRUARY 20, 2007--KERRY WENTWORTH b64268aiexv10w2.txt EX-10.2 46954
  Complete submission text file 0000950135-07-001043.txt   111380
Mailing Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111 212-994-8200
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 07648442
SIC: 2836 Biological Products, (No Diagnostic Substances)